⌘K

Login Start Free

Home/Filings/4/0001209500-09-000025

4//SEC Filing

Min Steve T. 4

Accession 0001209500-09-000025

CIK 0000930184other

View on SEC.gov Company Profile

Filed

Feb 12, 7:00 PM ET

Accepted

Feb 13, 4:15 PM ET

Size

8.3 KB

Accession

0001209500-09-000025

Insider Transaction Report

Form 4

Period: 2008-06-30

VALEANT PHARMACEUTICALS INTERNATIONALVRX

EVP and General Counsel

Transactions

Award
Common Stock
2008-06-30+39,039→ 39,039 total

Footnotes (1)

[F1]These restricted stock units are subject to specified performance criteria tied to total shareholder return as measured on certain specified dates.

Documents

2 files

Issuer

VALEANT PHARMACEUTICALS INTERNATIONAL

CIK 0000930184

Entity typeother

Related Parties

1

filerCIK 0001439079

Filing Metadata

Form type: 4
Filed: Feb 12, 7:00 PM ET
Accepted: Feb 13, 4:15 PM ET
Size: 8.3 KB

View on SEC.gov